Navigation Links
Pittsburgh Life Sciences Greenhouse Demonstrates a Region's Economic Resilience
Date:9/23/2009

nvestment in the commercialization of promising life sciences technologies.

Summary of PLSG Accomplishments to Date:

  • The PLSG has invested $14.7 million directly into 60 companies to help leverage over $500 million in additional capital.
  • The PLSG has assisted nearly 300 clients/companies through its Executive-in-Residence program.
  • The PLSG has invested $15.2 million in venture capital funds to help leverage an additional $110 million in total funding.
  • The PLSG's SBIR Advance program has assisted nearly 100 companies with their federal grant strategies. To date, these companies have received over $18 million in federal grant funding.
  • The PLSG has provided 27 early stage companies and venture capital and life sciences organizations with office and laboratory space in its incubator.
  • The PLSG has assisted 13 life sciences companies with relocating to the region and is working with other companies to establish operations in western Pennsylvania.
  • The PLSG has leveraged $2.4 million in federal grant money to help provide core and customized workforce training to over 6,000 trainees since September, 2005.
  • The PLSG has helped create 5,000 jobs directly/indirectly including university faculty and facilities. (300+ jobs created in invested companies and 1,000+ jobs in PLSG active companies/clients)
  • 30 executives have participated in the PLSG EIR program: 7 are currently active with PLSG and 20 former EIRs remain in the region.
  • The regional life sciences company formation rate has increased from 2-3 per year to 15-20 new companies per year.

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The Pittsburgh Life
'/>"/>

SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. The Pittsburgh Life Sciences Greenhouse Starts 2009 With Investment Momentum
2. Delcath Adds University of Pittsburgh Medical Center to Phase III Trial
3. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
4. Opening Dedication of the New John G. Rangos Sr. Research Center at the New Childrens Hospital of Pittsburgh of UPMC Campus in Lawrenceville
5. Pittsburgh Technology Council Announces Technology 50
6. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
7. Pittsburgh Region Middle School Students Participate in Hands-on Tissue Engineering Summer Camp
8. Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
9. The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments
10. The Pittsburgh Life Sciences Greenhouse Invests $100,000 in ParentPlus
11. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... The Conference Forum announced the ... Clinical Trials conference taking place on September 19-20 at ... , Disruptive thinkers from Novartis, Pfizer, Eli Lilly, Shire, ... to reduce expensive infrastructure, engage patients and generate credible ... big, or novel, or it must change the very ...
(Date:5/22/2013)... Genedata, a leading provider of ... and life science research, today announced AB Enzymes ... its bioinformatics platform for strain genome data management ... AB Enzymes, one of the world’s oldest and ... Genedata Selector accompanied by bioinformatics consulting services. Genedata ...
(Date:5/22/2013)... 2013 Alton Housing Authority was hit by ... said that their presence has already caused the company ... avoid such big spending, My Cleaning Products shared a way ... was said in the report that to clear the ... from that, its employees also attended a mandatory training on ...
(Date:5/21/2013)... First patients dosed with PSX1002, ... designed using Prosonix, particle engineering platform Prosonix, ... inhaled Respiratory Medicines by Design , has initiated ... assess its effect on lung function and the safety ... to severe chronic obstructive pulmonary disease (COPD). The first ...
Breaking Biology Technology:Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
... Pharmaceutical Manufacturing and Biotechnology Middle East (PABME) 27-29 ... ... The Middle East,market for pharmaceutical manufacturing and biotechnology, already valued,at over US$ ... -- Dubai is the commercial, scientific and financial center of the ...
... Conference Call to be Held on September 6, 2007 ... / 5:00 am (Pacific) / 8:00 pm (Beijing/Hong Kong), ... Inc. (NYSE: WX ) ("WuXi PharmaTech" or ,the ... outsourcing company, today announced that it will release,unaudited financial ...
... Reduced Tumor Growth by ... - Findings Confirm Key Aspects of Bavituximab,s Mechanism of Action in ... Combination with Radiation Therapy -, - Results Further Support Future Clinical Trials ... Combination With Radiation Therapy -, TUSTIN, Calif., ...
Cached Biology Technology:WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007 2WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007 3Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer 2Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer 3Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer 4Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer 5
(Date:5/21/2013)... experts , Where? Copenhagen, Denmark: Bella ... June 2013 , Why? An ... and policy developments, manufacturing and installation, drawing on leading ... its 2013 edition from a record of more than ... than 240 plenary and oral presentations, more than 460 ...
(Date:5/21/2013)... ANDOVER, Mass. , May 21, 2013 ... that CX50 xMATRIX, the world,s first portable ultrasound with ... Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available ... Paris at the EuroPCR, official ... (EAPCI), May 21-24. Since its launch in ...
(Date:5/20/2013)... Bacteria resistant to the antibiotic colistin are also ... human body, according to a study in ... American Society for Microbiology. Cross-resistance to colistin and ... the body against bacterial attack, could mean that ... saddled with a crippled immune response. Colistin is ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... to play a pivotal role in the inception of Darwin’s ... of their significance when he collected them during his voyage ... to predict the impact the vast amount of marine microbial ... by J. Craig Venter, Ph.D., and his team ?will have ...
... fixed nitrogen, the building block of life, after all. Instead, ... twice the amount of nitrogen fixing as the Atlantic, say ... title of an accompanying News and Views piece says it ... , It's important to have a global picture ...
... to many of the same health problems as tobacco smoke, ... according to a new study by researchers at Yale School ... illicit drug in the United States, and abuse of the ... today's Archives of Internal Medicine. First author Jeanette M. Tetrault, ...
Cached Biology News:Darwin's famous finches and Venter's marine microbes 2Darwin's famous finches and Venter's marine microbes 3Darwin's famous finches and Venter's marine microbes 4Darwin's famous finches and Venter's marine microbes 5New findings blow a decade of assumptions out of the water 2New findings blow a decade of assumptions out of the water 3Migration played key role in HIV spread in South Africa 2
ERalpha (Ser 104/106)...
Agarose, pulse field, 250 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Agarose, pulse field, 100 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Biology Products: